Title:
PHARMACEUTICAL COMPOSITION OF PROLYL HYDROXYLASE INHIBITOR AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2020/177681
Kind Code:
A1
Abstract:
The present application provides a pharmaceutical composition of a prolyl hydroxylase inhibitor and a preparation method therefor. In particular, the present application provides a composition comprising a compound represented by formula (I) or a pharmacologically acceptable salt thereof and at least one water-soluble filler. The composition provided by the present application has a rapid dissolution rate and good stability.
Inventors:
YANG ZHILIANG (CN)
SHI LEI (CN)
WANG LUYING (CN)
SHI LEI (CN)
WANG LUYING (CN)
Application Number:
PCT/CN2020/077560
Publication Date:
September 10, 2020
Filing Date:
March 03, 2020
Export Citation:
Assignee:
JIANGSU HENGRUI MEDICINE CO (CN)
SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD (CN)
SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD (CN)
International Classes:
A61K9/20; A61K9/48; A61K31/44; A61P7/06
Domestic Patent References:
| WO2017059623A1 | 2017-04-13 |
Foreign References:
| CN105130888A | 2015-12-09 | |||
| CN105130888A | 2015-12-09 |
Other References:
NEPHROL DIAL TRANSPLANT, vol. 17, 2002, pages 2 - 7
JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, 2013, pages 9369 - 9402
"Chinese Pharmacopoeia", vol. 4, 2015, article "Second Method of General Rule 0931"
JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, 2013, pages 9369 - 9402
"Chinese Pharmacopoeia", vol. 4, 2015, article "Second Method of General Rule 0931"
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF:
Previous Patent: COMMUNICATION METHOD AND COMMUNICATION APPARATUS
Next Patent: MOTION VECTOR MANAGEMENT FOR DECODER SIDE MOTION VECTOR REFINEMENT
Next Patent: MOTION VECTOR MANAGEMENT FOR DECODER SIDE MOTION VECTOR REFINEMENT